Bovi-Shield GOLD® 5 Now Labeled With Extended, Stronger Protection

Producers can take respiratory protection to the next level

NEW YORK — Sept. 27, 2010 — Pfizer Animal Health announces enhanced respiratory protection for Bovi-Shield GOLD® 5.* This trusted vaccine is now labeled to prevent respiratory disease caused by infectious bovine rhinotracheitis (IBR) with at least a nine-month duration of immunity. Bovi-Shield GOLD 5 also offers an extended duration of immunity for bovine viral diarrhea (BVD) Types 1 and 2 of at least nine months. 
“Producers can rest assured that Bovi-Shield GOLD is working to help protect cattle from respiratory disease during critical disease exposure points,” says Michael Nichols, DVM, Veterinary Operations, Pfizer Animal Health. “Stressed cattle are more susceptible to disease challenges. That’s why it is so valuable to vaccinate cattle prior to these challenges with a product that has an extended duration of immunity and promises to help prevent respiratory disease.”
Bovi-Shield GOLD 5 is the first and only vaccine that is approved to prevent IBR respiratory disease for at least nine months when administered by the subcutaneous route. In addition, it is the only vaccine that aids in the prevention of respiratory disease caused by BVD Types 1 and 2 for at least nine months when administered by the subcutaneous route. 
“When it comes to IBR and BVD, most vaccines aren’t labeled for a specific duration of immunity,” Dr. Nichols says. “For those that are, the best offer at least 182 days and 206 days of protection, respectively. This may not be sufficient to help protect beef calves from branding to weaning or during an extended feeding period — or to help protect dairy heifers until they receive their first reproductive vaccines before breeding.” 
A highly contagious disease, IBR is one of the most common virus infections in cattle in the U.S. and has been found in all areas of the country. In fact, IBR and BVD Types 1 and 2 are leading causes of bovine respiratory disease (BRD) — a disease costing the beef industry up to $1 billion annually from death, reduced feed efficiency and treatment costs.1 
In addition to IBR and BVD Types 1 and 2, bovine respiratory syncytial virus (BRSV) and parainfluenza type 3 (PI3) also can help open the door to secondary bacterial infections that may lead to BRD, adds Dr. Nichols.2  
In fact, according to 2007 National Animal Health Monitoring System data, bovine respiratory disease — commonly known as pneumonia in the dairy industry — is the second leading cause of death in heifer calves prior to weaning (22.5 percent of deaths) and the leading cause of death of weaned heifers (46.5 percent of all deaths).3
“Producers should be careful to choose a vaccine that helps protect against viral agents that can lead to BRD,” Dr. Nichols says. “Bovi-Shield GOLD 5 now provides a nine-month duration of immunity against respiratory disease caused by BVD Types 1 and 2 and IBR, and has demonstrated an ability to prevent respiratory disease caused by IBR. Bovi-Shield GOLD 5 also helps protect against BRSV and PI3. Combined, these label claims will help producers save time and money in the long run.”
Pfizer Animal Health, a business of Pfizer Inc., is a world leader in discovering and developing innovative animal prescription medicines and vaccines, investing an estimated $300 million annually. Beyond the U.S., Pfizer Animal Health also supports veterinarians and their customers in more than 60 countries around the world. For more information on how Pfizer Animal Health works to ensure a safe, sustainable global food supply with healthy livestock and poultry, or how Pfizer Animal Health helps companion animals and horses to live longer, healthier lives, visit

*The following vaccines are labeled to prevent respiratory disease caused by infectious bovine rhinotracheitis
(IBR) when administered by the subcutaneous route: Bovi-Shield® IBR, Bovi-Shield GOLD® IBR-BVD, Bovi-Shield GOLD 4, Bovi-Shield GOLD 5, Bovi-Shield GOLD FP® 5, Bovi-Shield GOLD FP 5 L5 HB and Bovi-Shield GOLD FP 5 VL5 HB.

Michelle Tollefson
Pfizer Animal Health

Laura Pires
Pfizer Animal Health

Rachel Torbert
Bader Rutter
1Brodersen BA, Bovine Respiratory Syncytial Virus. Vet Clin Food Anim 26 (2010) 323- 333.
2Ellis JA. Bovine parainfluenza-3 virus, Vet Clin Food Anim, 2010 (In press).
3NAHMS Dairy 2007 Part I: Reference of Dairy Cattle Health and Management Practices in the United States, October 2007. Available at: http://www.aphis.usda. Accessed July 2010.
All brands are the property of Pfizer Inc., its affiliates and/or its licensors. ©2010 Pfizer Inc. All rights reserved. BSD10016.



Mon–Fri, 8:30am–6:30pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.